Revance Therapeutics Inc. (RVNC) Climbed 16.98% or 3.54 To Price $24.39 On Tuesday


Revance Therapeutics Inc. (RVNC) climbed 16.98% or 3.54 to $24.39. It is around 873416 shares traded, which is 397.79% compare to the average total volume 219569. The market cap of RVNC is $902.13 million. The year to date change is -27.27%. The 52 week price range is from $19.62 to $37.45. Price of RVNC have changed 5.04% during last week. It have changed -16.47% over last month, -23.63% over last 3 months, -27.60% over last 6 months and -19.81% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RVNC is 22.94. It is -5.95% below current price. The 200-day Moving Averages for RVNC is 27.72. It is 13.65% above current price. The 52-week High is 37.45. It is 53.55% from the current price. The 52-week Low is 19.62. It is -19.56% from current price.

There are some statistics of RVNC. It is has market cap $902.13 million. The share outstanding is 36.99 million. The average volume is 219569. The percent of top 15 Institution holding is 108.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RVNC is -85.06%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RVNC is -68.55%.


Tags:

Share this post